Related Experiment Videos

Simpson-Golabi-Behmel syndrome: disproportionate fetal overgrowth and elevated maternal serum alpha-fetoprotein

R M Hughes-Benzie1, J L Tolmie, M McNay

  • 1Division of Genetics, University of Ottawa, Canada.

Prenatal Diagnosis
|April 1, 1994
PubMed

Insights

Simpson-Golabi-Behmel syndrome, a genetic disorder causing overgrowth, can potentially be diagnosed prenatally. Elevated maternal serum alpha-fetoprotein and specific fetal growth patterns are key indicators.

Area of Science:

  • Genetics
  • Prenatal Diagnosis
  • Medical Diagnostics

Background:

  • Simpson-Golabi-Behmel (SGB) syndrome is an X-linked genetic disorder.
  • Characterized by pre- and postnatal overgrowth, distinctive facial features, and organ and skeletal abnormalities.

Observation:

  • A case report details an affected male diagnosed at 16 weeks' gestation.
  • Elevated maternal serum alpha-fetoprotein (MSAFP) was noted during prenatal screening.
  • Fetal ultrasound revealed disproportionate growth, including macrosomia, with a low head-to-abdominal circumference ratio and normal femur length.

Findings:

  • The study highlights the potential of elevated MSAFP as a prenatal marker for SGB syndrome.
  • Specific patterns of fetal overgrowth, such as macrosomia with altered circumference ratios, are observed.

Implications:

  • These findings suggest that fetal overgrowth combined with elevated MSAFP can aid in the prenatal diagnosis of SGB syndrome.
  • Early prenatal identification allows for timely genetic counseling and management planning.

Related Concept Videos